110 related articles for article (PubMed ID: 22694074)
1. Understanding the in-vivo relevance of S-nitrosothiols in insulin action.
Fernandes AB; Guarino MP; Macedo MP
Can J Physiol Pharmacol; 2012 Jul; 90(7):887-94. PubMed ID: 22694074
[TBL] [Abstract][Full Text] [Related]
2. Hepatic glutathione and nitric oxide are critical for hepatic insulin-sensitizing substance action.
Guarino MP; Afonso RA; Raimundo N; Raposo JF; Macedo MP
Am J Physiol Gastrointest Liver Physiol; 2003 Apr; 284(4):G588-94. PubMed ID: 12466146
[TBL] [Abstract][Full Text] [Related]
3. High-fat diet results in postprandial insulin resistance that involves parasympathetic dysfunction.
Afonso RA; Lautt WW; Schafer J; Legare DJ; Oliveira AG; Macedo MP
Br J Nutr; 2010 Nov; 104(10):1450-9. PubMed ID: 20594392
[TBL] [Abstract][Full Text] [Related]
4. Spontaneous liberation of nitric oxide cannot account for in vitro vascular relaxation by S-nitrosothiols.
Kowaluk EA; Fung HL
J Pharmacol Exp Ther; 1990 Dec; 255(3):1256-64. PubMed ID: 2175799
[TBL] [Abstract][Full Text] [Related]
5. Insulin sensitivity is mediated by the activation of the ACh/NO/cGMP pathway in rat liver.
Guarino MP; Correia NC; Lautt WW; Macedo MP
Am J Physiol Gastrointest Liver Physiol; 2004 Sep; 287(3):G527-32. PubMed ID: 15331351
[TBL] [Abstract][Full Text] [Related]
6. Co-administration of glutathione and nitric oxide enhances insulin sensitivity in Wistar rats.
Guarino MP; Macedo MP
Br J Pharmacol; 2006 Apr; 147(8):959-65. PubMed ID: 16491098
[TBL] [Abstract][Full Text] [Related]
7. Acute effects of exogenous nitric oxide on glucose uptake in skeletal muscle of normoglycaemic and diabetic rats.
McGrowder D; Ragoobirsingh D; Brown P
Med Sci Monit; 2006 Jan; 12(1):BR28-35. PubMed ID: 16369460
[TBL] [Abstract][Full Text] [Related]
8. The effects of thiol modulators on nitrergic nerve- and S-nitrosothiols-induced relaxation in duodenum.
Kıroğlu OE; Aydinoglu F; Oğülener N
J Basic Clin Physiol Pharmacol; 2013; 24(2):143-50. PubMed ID: 23412870
[TBL] [Abstract][Full Text] [Related]
9. S-Nitrosothiols as potential therapeutics to induce a mobilizable vascular store of nitric oxide to counteract endothelial dysfunction.
Perrin-Sarrado C; Zhou Y; Salgues V; Parent M; Giummelly P; Lartaud I; Gaucher C
Biochem Pharmacol; 2020 Mar; 173():113686. PubMed ID: 31678494
[TBL] [Abstract][Full Text] [Related]
10. Postprandial insulin resistance in Zucker diabetic fatty rats is associated with parasympathetic-nitric oxide axis deficiencies.
Afonso RA; Fernandes AB; Santos C; Ligeiro D; Ribeiro RT; Lima IS; Patarrao RS; Videira PA; Caldeira J; Macedo MP
J Neuroendocrinol; 2012 Oct; 24(10):1346-55. PubMed ID: 22672343
[TBL] [Abstract][Full Text] [Related]
11. Acute glucagon induces postprandial peripheral insulin resistance.
Patarrão RS; Lautt WW; Macedo MP
PLoS One; 2015; 10(5):e0127221. PubMed ID: 25961284
[TBL] [Abstract][Full Text] [Related]
12. Topically applied S-nitrosothiol-containing hydrogels as experimental and pharmacological nitric oxide donors in human skin.
Seabra AB; Fitzpatrick A; Paul J; De Oliveira MG; Weller R
Br J Dermatol; 2004 Nov; 151(5):977-83. PubMed ID: 15541075
[TBL] [Abstract][Full Text] [Related]
13. Understanding postprandial glucose clearance by peripheral organs: the role of the hepatic parasympathetic system.
Fernandes AB; Patarrão RS; Videira PA; Macedo MP
J Neuroendocrinol; 2011 Dec; 23(12):1288-95. PubMed ID: 21933289
[TBL] [Abstract][Full Text] [Related]
14. Acetylcholinesterase antagonist potentiated insulin action in fed but not fasted state.
Schafer J; Legare DJ; Lautt WW
J Pharmacol Exp Ther; 2010 May; 333(2):621-8. PubMed ID: 20133391
[TBL] [Abstract][Full Text] [Related]
15. S-nitrosating nitric oxide donors induce long-lasting inhibition of contraction in isolated arteries.
Alencar JL; Lobysheva I; Chalupsky K; Geffard M; Nepveu F; Stoclet JC; Muller B
J Pharmacol Exp Ther; 2003 Oct; 307(1):152-9. PubMed ID: 12954813
[TBL] [Abstract][Full Text] [Related]
16. SNAP and SIN-1 increase brain production of kynurenic acid.
Luchowski P; Urbanska EM
Eur J Pharmacol; 2007 Jun; 563(1-3):130-3. PubMed ID: 17391664
[TBL] [Abstract][Full Text] [Related]
17. S-Nitrosoglutathione exhibits greater stability than S-nitroso-N-acetylpenicillamine under common laboratory conditions: A comparative stability study.
Melvin AC; Jones WM; Lutzke A; Allison CL; Reynolds MM
Nitric Oxide; 2019 Nov; 92():18-25. PubMed ID: 31398487
[TBL] [Abstract][Full Text] [Related]
18. Defective hepatic nitric oxide action results in HISS-dependent insulin resistance in spontaneously hypertensive rats.
Afonso RA; Ribeiro RT; Macedo MP
Proc West Pharmacol Soc; 2004; 47():103-4. PubMed ID: 15633625
[TBL] [Abstract][Full Text] [Related]
19. The hyperglycemic effect of S-nitrosoglutathione in the dog.
McGowder D; Ragoobirsingh D; Dasgupta T
Nitric Oxide; 1999 Dec; 3(6):481-91. PubMed ID: 10637127
[TBL] [Abstract][Full Text] [Related]
20. The design of nitric oxide donor drugs: s-nitrosothiol tDodSNO is a superior photoactivated donor in comparison to GSNO and SNAP.
Kumari S; Sammut IA; Giles GI
Eur J Pharmacol; 2014 Aug; 737():168-76. PubMed ID: 24858367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
